Glycopyrrolate Tablets, USP, 1 mg, Rx Only, 100 tablets per bottle, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ, 07724, NDC 0143-1250-01.
Published February 20, 2013 · Recall initiated: January 7, 2013
Summary
FDA records drug Class III recall D-164-2013, published February 20, 2013 and initiated January 7, 2013. Recalling firm: West-ward Pharmaceutical Corp.; Status: Terminated; Reported quantity: 1,185 Bottles; Lot: Lot #: 69001A. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- West-ward Pharmaceutical Corp.
- Distributor
- OH
- Lot
- Lot #: 69001A
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANicardipine Hydrochloride Injection 25 mg/10 mL (2.5 mg/mL), 10 mL single-use vials, Rx Only, Mfd. by ExelaJuly 17, 2013
- FDADonnatal Extentabs, 0.3888mg/46.8mg, 100-count bottle (NDC # 66213-421-10), Rx only Manufactured By: West-wardMay 8, 2013
- FDAEthambutol Hydrochloride Tablets, USP, 100 mg, 100-count tablets per bottle, Rx only, Mfd. for: VersapharmApril 10, 2013
- FDACiprofloxacin Tablets USP, 500 mg, 100-count bottle, Rx only, Manufactured for West-ward Pharmaceutical Corp.,April 3, 2013
- FDALac-Hydrin (ammonium lactate) Cream, 12%, packaged in a) 280 g (2 x 140 g tubes), NDC 10631-099-28; b) 385 gFebruary 20, 2013
- FDA"ESTRELLA***Empanadillas de Pizza" (Pizza turnovers)***5 units, 12 units and 24 units***Elaborado y EmpacadoFebruary 20, 2013
Questions about this recall
Was Glycopyrrolate Tablets, USP, 1 mg, Rx Only, 100 tablets per bottle, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ, 07724, NDC 0143-1250-01. recalled?
Yes. FDA published recall D-164-2013 on February 20, 2013. Reported hazard: Subpotent Drug
What should I do if I have this product?
Voluntary: Firm initiated · Letter